Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nutriband Inc. - Common Stock
(NQ:
NTRB
)
5.400
-0.100 (-1.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nutriband Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
UPDATE – Nutriband Signs Associate Partnership with Charlotte FC
April 04, 2025
From
Nutriband Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Signs Partnership Deal With Charlotte FC to Boost Brand Visibility
April 04, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Nutriband Signs Partnership Agreement with Charlotte FC
April 04, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica
October 17, 2024
Via
ACCESSWIRE
Stock Market Indices Suffer Significant Trend Change Following Friday's Session
February 21, 2025
In this video, I review the market warnings I've shared over the past three weeks and how Friday's session confirmed negative divergences across key metrics signaling weakness.
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.
February 21, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
February 13, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board
February 11, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™
February 07, 2025
The AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 countries including the United States, Europe,...
From
Nutriband Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 07, 2025
Via
Benzinga
On Friday, there are stocks with unusual volume. Let's take a look.
January 24, 2025
These stocks have an unusual volume in today's session
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 22, 2025
Via
Benzinga
Nutriband Issues Letter to Shareholders
December 31, 2024
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
December 27, 2024
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
December 04, 2024
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th
December 04, 2024
From
Nutriband Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 29, 2024
Via
Benzinga
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology
November 27, 2024
AVERSA Fentanyl has the potential to be the world's first and only abuse-deterrent opioid patch
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application
October 31, 2024
Via
ACCESSWIRE
Are Pharma Stocks Harmful To Your Financial Health ?
October 09, 2024
It seems time for the Securities and Exchange Commission to oversee stock advertising and consider a ban, or at least a danger warning label.
Via
Talk Markets
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Schedules Live Investor Webinar, Q&A Session
October 02, 2024
Via
Investor Brand Network
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17
October 02, 2024
Via
ACCESSWIRE
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Receipt of Notice of Allowance for China Patent Application Covering AVERSA(TM) Technology
September 24, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
September 24, 2024
EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:TEVA),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AMRX) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
September 24, 2024
From
FN Media Group LLC
Via
GlobeNewswire
NUTRIBAND RECEIVES CHINA PATENT NOTICE OF ALLOWANCE FOR ITS AVERSA™ ABUSE DETERRENT TRANSDERMAL TECHNOLOGY
September 24, 2024
Notice of Allowance received from Chinese National Intellectual Property Administration (CNIPA) for a patent application covering its Nutriband AVERSA™ abuse deterrent transdermal technology Nutriband...
Via
FinancialNewsMedia
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology
September 24, 2024
Via
ACCESSWIRE
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Inks Licensing Agreement to Use Bitrex(R) Aversive Agent for Flagship Product
September 20, 2024
Via
Investor Brand Network
Women Reach Settlement After Yale Nurse Switched Painkillers with Saline Solution
September 20, 2024
Via
Investor Brand Network
Topics
Lawsuit
Exposures
Financial
Legal
Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch
September 20, 2024
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.